Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53
Tirrò, Elena, Massimino, Michele, Romano, Chiara, Pennisi, Maria Stella, Stella, Stefania, Vitale, Silvia Rita, Fidilio, Annamaria, Manzella, Livia, Parrinello, Nunziatina Laura, Stagno, Fabio, Palumbo, Giuseppe Alberto, La Cava, Piera, Romano, Alessandra, Di Raimondo, Francesco, Vigneri, Paolo G
Published in Frontiers in oncology (18.02.2019)
Published in Frontiers in oncology (18.02.2019)
Get full text
Journal Article
BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein
Buffa, Pietro, Romano, Chiara, Pandini, Alessandro, Massimino, Michele, Tirrò, Elena, Di Raimondo, Francesco, Manzella, Livia, Fraternali, Franca, Vigneri, Paolo G
Published in The FASEB journal (01.03.2014)
Published in The FASEB journal (01.03.2014)
Get more information
Journal Article
Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity In CML Patients At Diagnosis
Giallongo, Cesarina, Parrinello, Nunziatina, Tibullo, Daniele, La Cava, Piera, Romano, Alessandra, Chiarenza, Annalisa, Stagno, Fabio, Vigneri, Paolo G., Palumbo, Giuseppe A., Raimondo, Francesco Di
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
“Real-life” Frontline Dasatinib Treatment in Unselected Elderly Patients with Chronic Myeloid Leukemia
Latagliata, Roberto, Stagno, Fabio, Annunziata, Mario, Abruzzese, Elisabetta, Iurlo, Alessandra, Sgherza, Nicola, Fava, Carmen, Gozzini, Antonella, Giglio, Gianfranco, Sorà, Federica, Leonetti Crescenzi, Sabrina, Bocchia, Monica, Crugnola, Monica, Gugliotta, Gabriele, Capodanno, Isabella, Galimberti, Sara, Feo, Costanzo, Porrini, Raffaele, Pregno, Patrizia, Breccia, Massimo, Vigneri, Paolo G, Trawinska, Malgorzata Monika, Guarini, Attilio, Alimena, Giuliana
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
High BCR-ABL/GUSIS Levels At Diagnosis Are Associated With Unfavorable Responses To Imatinib
Vigneri, Paolo G, Stagno, Fabio, Stella, Stefania, Cupri, Alessandra, Forte, Stefano, Massimino, Michele, Antolino, Agostino, Caracciolo, Clementina, Nocilli, Laura, Impera, Stefana, Musolino, Caterina, Turri, Diamante, Russo, Mario, Tomaselli, Carmen, Rizzo, Michele, Musso, Maurizio, Morabito, Fortunato, Levato, Luciano, Manzella, Livia, Muller, Martin C, Hochhaus, Andreas, Di Raimondo, Francesco
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
The e13a2 BCR-ABL1 Fusion Transcript Is a Candidate Adverse Prognostic Factor In Chronic Myeloid Leukemia Patients Treated Frontline With Imatinib Mesylate
Castagnetti, Fausto, Gugliotta, Gabriele, Breccia, Massimo, Iurlo, Alessandra, Abruzzese, Elisabetta, Albano, Francesco, Vigneri, Paolo G, Cavazzini, Francesco, Orlandi, Ester, Pregno, Patrizia, Annunziata, Mario, Galieni, Piero, Montefusco, Enrico, Fava, Carmen, Palandri, Francesca, Venturi, Claudia, Soverini, Simona, Testoni, Nicoletta, Alimena, Giuliana, Saglio, Giuseppe, Pane, Fabrizio, Martinelli, Giovanni, Cavo, Michele, Baccarani, Michele, Rosti, Gianantonio
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
High BCR-ABL Levels At Diagnosis Are Associated with Unfavorable Responses to Imatinib Mesylate
Vigneri, Paolo G, Stagno, Fabio, Stella, Stefania, Cupri, Alessandra, Forte, Stefano, Massimino, Michele, Antolino, Agostino, Caracciolo, Clementina, Nocilli, Laura, Impera, Stefana, Musolino, Caterina, Turri, Diamante, Russo, Mario, Tomaselli, Carmen, Rizzo, Michele, Musso, Maurizio, Morabito, Fortunato, Levato, Luciano, Manzella, Livia, Mueller, Martin, Raimondo, Francesco Di
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article